The high correlation between CD90 expression and Gli1 and Gli3 expression in the cell lines and patient tissues suggested that SHH/Gli signalling might regulate the stem cell properties of CD90+ liver cancer cells, which was further supported by the analysis of large‐scale liver cancer expression profiles from the TCGA database. The gene discussed is THY1; the disease is liver cancer.